Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Dysplasia 1 Squamous Intraepithelial Lesions 1 Carcinoma, Basal Cell 1

Interventions

HhAntag691 15 sonidegib 5 cemiplimab 5 Nivolumab 5 Aminolevulinic Acid 5 daromun 4 Specimen Handling 4 Radiotherapy 3 Magnetic Resonance Spectroscopy 3 3-ingenyl angelate 3 tazarotene 2 relatlimab 2 Ipilimumab 2 IPI-926 2 Drug Evaluation 2 Celecoxib 2 Biopsy 2 talimogene laherparepvec 1 remetinostat 1 gusacitinib 1 endonuclease V, phage T4 1 X-Rays 1 Triamcinolone 1 Sutures 1 Surgical Procedures, Operative 1 Solutions 1 Papillomavirus Vaccines 1 Opdualag 1 Observation 1 Niacinamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Basal Cell × Chemoprevention × Clear all

NCT00025051 2013-03-22

Celecoxib in Preventing Skin Cancer

National Cancer Institute (NCI)

Phase 2 Withdrawn

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡